Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic

Urszula Grzybowska-Chlebowczyk1, Paulina Wysocka-Wojakiewicz2, Martyna Jasielska2

  • 1Department of Pediatrics, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.

Insights

Oxidative stress markers in children with inflammatory bowel disease (IBD) were evaluated. Contrary to expectations, IBD patients showed lower oxidized low-density lipoprotein (oxLDL) levels, though longer disease duration correlated with higher oxLDL and anti-oxLDL concentrations.

Area of Science:

  • Pediatric Gastroenterology
  • Cardiovascular Health
  • Oxidative Stress Research

Background:

  • Oxidative stress (OS) is increasingly recognized in the pathogenesis of inflammatory bowel disease (IBD).
  • Understanding OS status and atherosclerotic risk in pediatric IBD and functional gastrointestinal disorders (FGID) is crucial.
  • Previous research suggests a potential link between IBD and altered OS profiles.

Purpose of the Study:

  • To assess oxidative and antioxidative stress markers in children diagnosed with IBD.
  • To evaluate the risk of the atherosclerotic process in pediatric IBD and FGID patients.
  • To compare OS status between children with IBD and FGID.

Main Methods:

  • A prospective study involving 71 children over two years.
  • Laboratory tests to measure oxidative and antioxidative stress markers.
  • Intima-media complex (IMC) measurement in the carotid artery to assess atherosclerotic risk.

Main Results:

  • Lower OS values were observed more frequently in children with IBD compared to the FGID group.
  • The average concentration of oxidized low-density lipoprotein (oxLDL) was lower in IBD patients.
  • In IBD patients, higher oxLDL concentrations were associated with longer disease duration and elevated total cholesterol.
  • Higher anti-oxLDL concentrations were also more frequent in IBD patients with longer disease duration.

Conclusions:

  • The study did not support the hypothesis of depleted total antioxidant capacity and greater overall OS in pediatric IBD patients.
  • Longer disease duration in pediatric IBD is linked to increased concentrations of both oxLDL and anti-oxLDL.
  • These findings suggest a complex interplay between IBD duration, OS markers, and potential atherosclerotic risk in children.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
557
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
646
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
766
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.8K